Keros Therapeutics, Inc.
USD10.80
-0.13 (-1.14%)
CEO
Jasbir S. Seehra
IPO Date
2020-04-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.86
Prev. Close
$10.93
Day Low
$10.76
Day High
$11.14
52W Low
$9.69
52W High
$22.55
Market Cap
$0.35B
Volume
0.07M
| -3.2 |
| 31 Dec 2023 | FY | 100.0% | -101319.2% | -46.1% | -41.3% | 0.04 | 14.25 | -7.7 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -37.7% | -34.1% | 0.05 | 17.27 | -11.6 |
| 31 Dec 2021 | FY | 100.0% | -292.3% | -24.2% | -23.0% | 0.00 | 21.23 | -23.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -17.3% | -16.8% | 0.00 | 37.27 | -24.1 |
| 31 Dec 2019 | FY | -73.5% | -123.4% | -2493.7% | -112.7% | 2.58 | 1.99 | -14.4 |
| 31 Dec 2018 | FY | -1.1% | -13.4% | -10.5% | -4.9% | 0.06 | 2.23 | -133.6 |
| -8.1 |
| 30 Sept 2025 | Q3 | 97.2% | -51.0% | -1.0% | -1.0% | 0.02 | 29.86 | -22.1 |
| 30 Jun 2025 | Q2 | 98.0% | -169.0% | -4.3% | -4.1% | 0.03 | 21.11 | -4.4 |
| 31 Mar 2025 | Q1 | 100.0% | 70.3% | 20.4% | 18.9% | 0.03 | 19.29 | 0.7 |
| 31 Dec 2024 | Q4 | 89.1% | -1513.0% | -8.1% | -7.5% | 0.03 | 21.45 | -3.5 |
| 30 Sept 2024 | Q3 | 19.1% | -13648.5% | -9.9% | -9.1% | 0.04 | 19.03 | -9.9 |
| 30 Jun 2024 | Q2 | 100.0% | -122316.2% | -10.8% | -9.9% | 0.03 | 20.37 | -8.7 |
| 31 Mar 2024 | Q1 | 100.0% | -51944.6% | -9.5% | -8.9% | 0.03 | 24.74 | -11.4 |
| 31 Dec 2023 | Q4 | 100.0% | -28142.0% | -12.1% | -10.9% | 0.04 | 14.25 | -7.4 |